Abstract
Remote monitoring is a key step in clinical research that produces reliable, high-quality, and scientifically sound data from clinical studies. According to ICH-GCP, the sponsor has the responsibility for preserving the monitoring of data for the continuing trials. Due to the development of remote monitoring, the monitoring of the trials has become fairly simple for the CRA (a person assigned by the sponsor to monitor the ongoing trials). The primary benefit of remote monitoring is that it speeds up the on-time completion of work by reducing the time required for final trial reports output. It significantly lowers the sponsor's travel costs. Reducing the time between site monitoring enhances the accuracy and timeliness of study data and increases the safety of human subjects participating in a clinical trial. By using the secure off-site electronic health records access is currently utilized for clinical care, and also used to validate the source documentation. This article provides an overview of the offsite monitoring processes involved and standards adopted in remote monitoring.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Asian Journal of Pharmaceutical Research and Development
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
